Online Message×
Click switch
Preclinical research
Micromolecular Drugs Bioanalysis
Our Bioanalysis Department can provide bioanalysis of micromolecular drugs in accordance with standards of FDA/NMPA GLP to support the selection and development, preclinical and clinical research of micromolecular drugs.
  • Service team for bioanalysis of micromolecular drugs composed of experienced employeesEmployment of verified laboratory information management system (Watson LIMS 7.2) to manage samples and experiment dataReview by US FDA and GLP certificate by NMPA Bioanalysis of micromolecular drugs for global clients
  • Early selection of DMPK/ADME in vitro and in vivoPreclinical GLP-based pharmacology and toxicology experimentBioequivalence (BE) experiment of generic drugsSample analysis of global clinical trialsDevelopment of LC-MS/MS method and verification of methodologyDevelopment, transfer and optimization of LC-MS/MS method for determination of drug concentration in biological matrixFast verification of methodology in laboratories to support needs of potential projectsDevelopment, transfer and verification of methodology          Synthesis of standards and isotope internal standardsShort-term and fast synthesis of standards and isotope internal standards in Chemical Synthesis and Radiosynthesis Laboratory
  • Thermo Q Exactive HF-XSCIEX Triple Quad 6500+SCIEX Triple Quad 5500Shimadzu LCMS-8050SCIEX API 4000Waters UPLCShimadzu UHPLCThermo Vanquish Flex UHPLCICP-MS
Relevant laboratories
Relevant articles